If the clinical sample contains viable virus, cytopathic effects due to the herpes virus replication occur after several days, signaling the recovery of HSV-1/2 and VZV from the sample.
Our lab focuses primarily on drug development, specifically on novel small-molecule inhibitors of herpes simplex virus replication. We are investigating their structure-activity relationships, their ...